Suppr超能文献

脂蛋白(a)上的氧化磷脂引发人体动脉壁炎症和炎性单核细胞反应。

Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans.

作者信息

van der Valk Fleur M, Bekkering Siroon, Kroon Jeffrey, Yeang Calvin, Van den Bossche Jan, van Buul Jaap D, Ravandi Amir, Nederveen Aart J, Verberne Hein J, Scipione Corey, Nieuwdorp Max, Joosten Leo A B, Netea Mihai G, Koschinsky Marlys L, Witztum Joseph L, Tsimikas Sotirios, Riksen Niels P, Stroes Erik S G

机构信息

From Department of Vascular Medicine (F.M.V.d.V., M.N., E.S.G.S.), Department of Molecular Cell Biology, Sanquin Research (J.K., J.D.v.B.), Experimental Vascular Biology, (J.v.d.B.), Department of Radiology (A.J.N.), and Department of Nuclear Medicine (H.J.V.), Academic Medical Center, Amsterdam, the Netherlands; Departments of Internal Medicine (S.B., L.A.B.J., M.G.N., N.P.R.) and Pharmacology-Toxicology (N.P.R.), Radboud UMC, Nijmegen, the Netherlands; Sulpizio Cardiovascular Center, Division of Cardiovascular Medicine (C.Y., S.T.) and Division of Endocrinology and Metabolism, Department of Medicine (J.L.W.), University California, San Diego, La Jolla; St. Boniface Hospital Research Centre, University of Manitoba, Winnipeg, Canada (A.R.); Department of Chemistry, Biochemistry and Pharmacology, University of Windsor, Windsor, Canada (C.S.); and Robarts Research Institute, Schulich School of Medicine, Western University, London, Canada (M.L.K.).

出版信息

Circulation. 2016 Aug 23;134(8):611-24. doi: 10.1161/CIRCULATIONAHA.116.020838. Epub 2016 Aug 5.

Abstract

BACKGROUND

Elevated lipoprotein(a) [Lp(a)] is a prevalent, independent cardiovascular risk factor, but the underlying mechanisms responsible for its pathogenicity are poorly defined. Because Lp(a) is the prominent carrier of proinflammatory oxidized phospholipids (OxPLs), part of its atherothrombosis might be mediated through this pathway.

METHODS

In vivo imaging techniques including magnetic resonance imaging, (18)F-fluorodeoxyglucose uptake positron emission tomography/computed tomography and single-photon emission computed tomography/computed tomography were used to measure subsequently atherosclerotic burden, arterial wall inflammation, and monocyte trafficking to the arterial wall. Ex vivo analysis of monocytes was performed with fluorescence-activated cell sorter analysis, inflammatory stimulation assays, and transendothelial migration assays. In vitro studies of the pathophysiology of Lp(a) on monocytes were performed with an in vitro model for trained immunity.

RESULTS

We show that subjects with elevated Lp(a) (108 mg/dL [50-195 mg/dL]; n=30) have increased arterial inflammation and enhanced peripheral blood mononuclear cells trafficking to the arterial wall compared with subjects with normal Lp(a) (7 mg/dL [2-28 mg/dL]; n=30). In addition, monocytes isolated from subjects with elevated Lp(a) remain in a long-lasting primed state, as evidenced by an increased capacity to transmigrate and produce proinflammatory cytokines on stimulation (n=15). In vitro studies show that Lp(a) contains OxPL and augments the proinflammatory response in monocytes derived from healthy control subjects (n=6). This effect was markedly attenuated by inactivating OxPL on Lp(a) or removing OxPL on apolipoprotein(a).

CONCLUSIONS

These findings demonstrate that Lp(a) induces monocyte trafficking to the arterial wall and mediates proinflammatory responses through its OxPL content. These findings provide a novel mechanism by which Lp(a) mediates cardiovascular disease.

CLINICAL TRIAL REGISTRATION

URL: http://www.trialregister.nl. Unique identifier: NTR5006 (VIPER Study).

摘要

背景

脂蛋白(a)[Lp(a)]升高是一种常见的独立心血管危险因素,但其致病的潜在机制尚不清楚。由于Lp(a)是促炎氧化磷脂(OxPLs)的主要载体,其动脉粥样硬化血栓形成的部分机制可能通过该途径介导。

方法

采用包括磁共振成像、(18)F-氟脱氧葡萄糖摄取正电子发射断层扫描/计算机断层扫描和单光子发射计算机断层扫描/计算机断层扫描在内的体内成像技术,依次测量动脉粥样硬化负担、动脉壁炎症和单核细胞向动脉壁的迁移。采用荧光激活细胞分选分析、炎症刺激试验和跨内皮迁移试验对单核细胞进行体外分析。利用训练免疫体外模型对Lp(a)对单核细胞的病理生理学进行体外研究。

结果

我们发现,与Lp(a)正常的受试者(7mg/dL[2-28mg/dL];n=30)相比,Lp(a)升高的受试者(108mg/dL[50-195mg/dL];n=30)动脉炎症增加,外周血单核细胞向动脉壁的迁移增强。此外,从Lp(a)升高的受试者中分离出的单核细胞保持长期的预激活状态,刺激后迁移和产生促炎细胞因子的能力增加证明了这一点(n=15)。体外研究表明,Lp(a)含有OxPL,并增强了健康对照受试者来源的单核细胞中的促炎反应(n=6)。通过使Lp(a)上的OxPL失活或去除载脂蛋白(a)上的OxPL,这种效应明显减弱。

结论

这些发现表明,Lp(a)诱导单核细胞向动脉壁迁移,并通过其OxPL含量介导促炎反应。这些发现为Lp(a)介导心血管疾病提供了一种新机制。

临床试验注册

网址:http://www.trialregister.nl。唯一标识符:NTR5006(VIPER研究)。

相似文献

1
Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans.
Circulation. 2016 Aug 23;134(8):611-24. doi: 10.1161/CIRCULATIONAHA.116.020838. Epub 2016 Aug 5.
2
Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a).
J Clin Lipidol. 2015 Jul-Aug;9(4):533-41. doi: 10.1016/j.jacl.2015.04.005. Epub 2015 Apr 25.
5
Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation.
Circ Res. 2020 May 8;126(10):1346-1359. doi: 10.1161/CIRCRESAHA.119.316206. Epub 2020 Mar 12.
6
Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.
J Am Coll Cardiol. 2019 May 7;73(17):2150-2162. doi: 10.1016/j.jacc.2019.01.070.
7
Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein(a), Contribute to Monocyte Inflammation.
Arterioscler Thromb Vasc Biol. 2024 Mar;44(3):720-740. doi: 10.1161/ATVBAHA.123.319937. Epub 2024 Jan 25.
8
Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a).
J Clin Lipidol. 2016 May-Jun;10(3):594-603. doi: 10.1016/j.jacl.2016.01.005. Epub 2016 Mar 8.
9
A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma.
J Lipid Res. 2008 Oct;49(10):2230-9. doi: 10.1194/jlr.M800174-JLR200. Epub 2008 Jul 1.
10
New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease.
Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2094-9. doi: 10.1161/01.ATV.0000280571.28102.d4. Epub 2007 Jul 12.

引用本文的文献

2
Impact of severe dyslipidemia on renal function: A cross-sectional study.
Medicine (Baltimore). 2025 Aug 29;104(35):e44131. doi: 10.1097/MD.0000000000044131.
3
Maladaptive trained immunity in viral infections.
J Clin Invest. 2025 Sep 2;135(17). doi: 10.1172/JCI192469.
4
Multiplexed Quantification of First-Trimester Serum Biomarkers in Healthy Pregnancy.
Int J Mol Sci. 2025 Aug 18;26(16):7970. doi: 10.3390/ijms26167970.
5
COVID-19: A Disease Driven by Protease/Antiprotease Imbalance? A Specific Review Five Years into the Pandemic.
Infect Drug Resist. 2025 Aug 8;18:3967-3975. doi: 10.2147/IDR.S541205. eCollection 2025.
6
Lipoprotein (a) in primary cardiovascular disease prevention is actionable today.
Am Heart J Plus. 2025 Jul 21;57:100581. doi: 10.1016/j.ahjo.2025.100581. eCollection 2025 Sep.
7
Trained immunity: novel perspectives in diabetes and associated complications.
Front Immunol. 2025 Jul 17;16:1613602. doi: 10.3389/fimmu.2025.1613602. eCollection 2025.
8
Untargeted plasma metabolite detection in sudden sensorineural hearing loss: identifying key metabolic signatures.
Front Mol Biosci. 2025 Jul 14;12:1567064. doi: 10.3389/fmolb.2025.1567064. eCollection 2025.
9
Hepatic Lipoprotein Metabolism: Current and Future In Vitro Cell-Based Systems.
Biomolecules. 2025 Jul 2;15(7):956. doi: 10.3390/biom15070956.
10
Harnessing Mitochondrial Transplantation to Target Vascular Inflammation in Cardiovascular Health.
JACC Basic Transl Sci. 2025 Jul 25;10(8):101331. doi: 10.1016/j.jacbts.2025.101331.

本文引用的文献

1
Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis.
J Lipid Res. 2016 Jun;57(6):917-24. doi: 10.1194/jlr.R051870. Epub 2015 Dec 18.
2
Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a).
J Lipid Res. 2015 Dec;56(12):2273-85. doi: 10.1194/jlr.M060210. Epub 2015 Oct 16.
3
A sense of excitement for a specific Lp(a)-lowering therapy.
Lancet. 2015 Oct 10;386(10002):1427-9. doi: 10.1016/S0140-6736(15)60638-9. Epub 2015 Jul 22.
4
Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study.
Lancet. 2015 Oct 10;386(10002):1472-83. doi: 10.1016/S0140-6736(15)61252-1. Epub 2015 Jul 22.
6
Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity.
Science. 2014 Sep 26;345(6204):1251086. doi: 10.1126/science.1251086.
7
mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity.
Science. 2014 Sep 26;345(6204):1250684. doi: 10.1126/science.1250684.
8
In vivo imaging of enhanced leukocyte accumulation in atherosclerotic lesions in humans.
J Am Coll Cardiol. 2014 Sep 9;64(10):1019-29. doi: 10.1016/j.jacc.2014.06.1171.
10
PET imaging of inflammation in atherosclerosis.
Nat Rev Cardiol. 2014 Aug;11(8):443-57. doi: 10.1038/nrcardio.2014.80. Epub 2014 Jun 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验